Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with non-alcoholic fatty liver disease (NAFLD) or a liver disease of unknown cause, and you drink no more than about 4 drinks per day (men) or about 2.5 drinks per day (women)
- You are between 45 and 75 years old
- You have significant liver scarring (advanced fibrosis or cirrhosis), confirmed by a liver biopsy, a special ultrasound scan, or blood tests and imaging
- You have a close family member (parent, sibling, or child) who had primary liver cancer, or you carry certain rare gene changes linked to liver cancer risk (confirm with trial site)
- You are a man with type 2 diabetes or obesity AND you carry at least three specific gene variants related to liver fat processing (confirm with trial site)
- You are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You drink more alcohol than the limits described above (roughly more than 4 drinks/day for men or 2.5 drinks/day for women)
- You have chronic hepatitis caused by a virus (such as hepatitis B or C) or by your immune system attacking your liver
- You have been diagnosed with an inherited liver disease that raises liver cancer risk, such as hereditary hemochromatosis, Wilson's disease, or Alpha-1 Antitrypsin deficiency
- You regularly take medications known to cause fat build-up or damage in the liver (confirm with trial site)
- You have already been diagnosed with primary liver cancer before the study begins
- You have another serious health condition where life expectancy is expected to be less than two years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02 5503 6595
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The quantify the impact of genetic risk factors for NAFLD-HCC and their interaction; The quantify the impact of genetic risk factors for NAFLD-HCC and their interaction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.